J Kenneth Zuerblis

Affiliations

  • Director at Stemline Therapeutics Inc (STML), 2020-06-10
  • Evp, Chief Financial Officer at Savient Pharmaceuticals Inc (SVNT), 2012-02-13
  • Director at Immunomedics Inc (IMMU), 2011-12-09
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
STML $11.14 1,000 Director 11,963 2014-09-02 Filing
STML $16.38 700 Director 10,963 2013-05-30 Filing
STML $16.38 200 Director 10,263 2013-05-30 Filing
STML $15.86 1,000 Director 10,063 2013-05-29 Filing
STML $15.86 500 Director 9,063 2013-05-29 Filing